- Home
- ALTO vs ALDX Comparison
ALTO vs ALDX Comparison
Compare ALTO & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTO
- ALDX
- Stock Information
- Founded
- ALTO 2003
- ALDX 2004
- Country
- ALTO United States
- ALDX United States
- Employees
- ALTO N/A
- ALDX N/A
- Industry
- ALTO Major Chemicals
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- ALTO Industrials
- ALDX Health Care
- Exchange
- ALTO Nasdaq
- ALDX Nasdaq
- Market Cap
- ALTO 123.0M
- ALDX 133.7M
- IPO Year
- ALTO N/A
- ALDX 2014
- Fundamental
- Price
- ALTO $0.87
- ALDX $2.18
- Analyst Decision
- ALTO Strong Buy
- ALDX Strong Buy
- Analyst Count
- ALTO 1
- ALDX 2
- Target Price
- ALTO $5.50
- ALDX $9.50
- AVG Volume (30 Days)
- ALTO 329.1K
- ALDX 1.5M
- Earning Date
- ALTO 05-07-2025
- ALDX 05-20-2025
- Dividend Yield
- ALTO N/A
- ALDX N/A
- EPS Growth
- ALTO N/A
- ALDX N/A
- EPS
- ALTO N/A
- ALDX N/A
- Revenue
- ALTO $951,169,000.00
- ALDX N/A
- Revenue This Year
- ALTO N/A
- ALDX N/A
- Revenue Next Year
- ALTO $5.90
- ALDX N/A
- P/E Ratio
- ALTO N/A
- ALDX N/A
- Revenue Growth
- ALTO N/A
- ALDX N/A
- 52 Week Low
- ALTO $0.76
- ALDX $1.14
- 52 Week High
- ALTO $2.05
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- ALTO 41.28
- ALDX 35.31
- Support Level
- ALTO $0.81
- ALDX $1.90
- Resistance Level
- ALTO $0.92
- ALDX $2.89
- Average True Range (ATR)
- ALTO 0.07
- ALDX 0.22
- MACD
- ALTO 0.02
- ALDX 0.09
- Stochastic Oscillator
- ALTO 36.85
- ALDX 28.28
About ALTO Alto Ingredients Inc.
Alto Ingredients Inc is a producer of specialty alcohols and essential ingredients. The company serves five markets: Health, Home and Beauty, Food and Beverage, Essential Ingredients, and Renewable Fuels. Its customers include major food and beverage companies and consumer products manufacturers and distributors. The company operates under three segments: Marketing and distribution, Pekin Campus production, and Other production. The Marketing and distribution segment participates in marketing and merchant trading for alcohols and essential ingredients; Pekin Campus produces and sells products produced at the company's Pekin, Illinois, campus, and about half of the firm's revenue flows from this segment. Other production makes and sells from the company's other production facilities.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.